EX-FILING FEES 7 endra_ex107.htm FEE TABLE endra_ex107.htm

EXHIBIT 107

 

Calculation of Filing Fee Tables

Form S-1

(Form Type)

ENDRA Life Sciences Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered and Carry Forward Securities

 

 

Security

Type

Security Class

Title

Fee Calculation

or Carry

Forward

Rule

Amount

Registered

Proposed Maximum

Offering

Price Per

Unit

Maximum Aggregate

Offering

Price (1)

Fee

Rate

Amount of

Registration

Fee

Carry Forward

Form

Type

Carry Forward

File

Number

Carry Forward

Initial

effective

date

Filing Fee Previously

Paid In

Connection

with

Unsold

Securities

to be

Carried

Forward

Newly Registered Securities

Fees to Be

Paid

Equity

Common Stock, par value $0.0001 per share

457(a)

18,055,000(2)

$3.42(3)

$61,748,100

0.00015310

$9,453.64

Equity

Pre-Funded Warrants (4)

457(g)

-

-

-

-

-

Equity

Underwriter’s Warrants (4)

457(g)

-

-

-

-

-

Equity

Shares of Common Stock, par value $0.0001 per share, issuable upon exercise of Pre-Funded Warrants (5)

457(a)

-

-

-

-

-

 

 

 

 

Equity

Shares of Common Stock, par value $0.0001 per share, issuable upon exercise of Underwriter’s Warrants (6)

457(g)

722,200(2)

$5.13

$3,704,886

0.00015310

$567.22

 

 

 

 

-

-

-

Fees Previously Paid

-

-

-

-

-

-

-

Carry Forward Securities

Carry Forward Securities

-

-

-

-

-

-

-

-

-

Total Offering Amounts

$65,452,986

$10,020.86

Total Fees Previously Paid

-

Total Fee Offsets

-

Net Fees Due

$10,020.86

 

(1)

Pursuant to Rule 416(a) under the Securities Act, this registration statement shall also cover an indeterminate number of shares that may be issued and resold resulting from stock splits, stock dividends or similar transactions.

(2)

Includes shares of Common Stock and shares of Common Stock underlying underwriter’s warrants, as applicable, issuable upon exercise of the underwriter’s over-allotment option.

(3)

Estimated solely for the purpose of calculating the registration fee in accordance with Rule 457(a) under the Securities Act of 1933, as amended.

(4)

No fee pursuant to Rule 457(g) of the Securities Act.

(5)

The number of shares of Common Stock sold in the offering will be reduced on a one-for-one basis based on the number of shares of Common Stock underlying any Pre-Funded Warrants issued in the offering. Accordingly, the proposed maximum aggregate offering price of the Common Stock and Pre-Funded Warrants (including the Common Stock issuable upon exercise of the Pre-Funded Warrants), if any, as estimated for purposes of calculating the registration fee pursuant to Rule 457(c) under the Securities Act, is $61,748,100.

(6)

We have agreed to issue to the underwriter warrants to purchase the number of shares of Common Stock in the aggregate equal to 4% of the shares of Common Stock sold in this offering and the number of shares of Common Stock issuable upon exercise of the Pre-Funded Warrants sold in this offering. The underwriter’s warrants are exercisable for a price per share equal to 150% of the public offering price of a share of Common Stock.